QuVa Pharma Launches Cardioplegia Offering through a Compounding and Distribution Agreement with Hibernation Therapeutics for Adenocaine™ Solution

Access to improved AdenocaineTM  solution, a ready to administer heart arrest and cardioprotection innovation, is immediately available to hospitals nationwide SUGAR LAND, Texas – December 9, 2019 – QuVa Pharma, Inc. today announced it has signed a production and distribution agreement with Hibernation Therapeutics for its patented cardioplegia solution AdenocaineTM, the combination of Adenosine, Lidocaine […]